Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company based in China, dedicated to the research, development, and commercialization of innovative and generic therapies for eye diseases. Spun off from Lee's Pharmaceutical, the company has built a comprehensive pipeline covering both front-of-the-eye and back-of-the-eye diseases, including myopia, dry eye disease, glaucoma, and wet age-related macular degeneration. Their state-of-the-art manufacturing facility in Guangzhou is one of the most advanced in China, designed to meet international GMP standards. With a mix of in-house R&D and strategic global partnerships, Zhaoke aims to address significant unmet medical needs in the rapidly growing Chinese ophthalmic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaoke Guangzhou Biotech.